top of page
Browse by category
Search
First patient enrolled in Endogenex’ ReCET clinical study
Endogenex has enrolled the first patient in the Re-Cellularization via Electroporation Therapy ( ReCET) clinical study, multi-centre,...
Gene therapy converts omega-6 to omega-3 fatty acids to combat effects of childhood obesity
Using gene therapy, Shriners Children's St. Louis researchers including Director of Research, Dr Farshid Guilak and Senior Scientist Dr...
Cutting-edge nanoparticle therapy targets fat absorption to combat obesity
A cutting-edge nanoparticle system, engineered to deliver therapeutic molecules directly to the digestive tract, has shown significant...
FDA grants Breakthrough Therapy designation for Zealand Pharma’s survodutide
The FDA has granted Breakthrough Therapy designation to Zealand Pharma’s survodutide (BI 456906), a dual glucagon/GLP-1 receptor agonist...
Lilly and UK government announce £279 million collaboration to tackle population health challenges including obesity
Eli Lilly and Company has announced a strategic collaboration with the UK’s Department of Health and Social Care (DHSC), Department for...
ReCET procedure plus semaglutide may eliminate insulin dependency in T2D
A promising new treatment strategy for type 2 diabetes (T2D) that combines a novel procedure known as ReCET (Re-Cellularization via...
Browse by tag
bottom of page